Molecules of various pharmacologically-relevant sizes can cross the ultrasound-induced blood-brain barrier opening in vivo.
about
Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.Nanostructures: a platform for brain repair and augmentationEffects of the microbubble shell physicochemical properties on ultrasound-mediated drug delivery to the brainNon-Viral Nucleic Acid Delivery Strategies to the Central Nervous SystemThe mechanism of interaction between focused ultrasound and microbubbles in blood-brain barrier opening in mice.Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system.Real-time, transcranial monitoring of safe blood-brain barrier opening in non-human primates.Microbubbles and ultrasound increase intraventricular polyplex gene transfer to the brain.Transcranial pulsed ultrasound facilitates brain uptake of laronidase in enzyme replacement therapy for Mucopolysaccharidosis type I diseaseLocalized delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat brain using focused ultrasoundHigh intensity focused ultrasound as a tool for tissue engineering: Application to cartilage.Acoustic cavitation-based monitoring of the reversibility and permeability of ultrasound-induced blood-brain barrier openingNon-invasive delivery of stealth, brain-penetrating nanoparticles across the blood-brain barrier using MRI-guided focused ultrasound.The size of blood-brain barrier opening induced by focused ultrasound is dictated by the acoustic pressure.An IVUS transducer for microbubble therapiesThe application of sparse arrays in high frequency transcranial focused ultrasound therapy: a simulation studyQuantification of transient increase of the blood-brain barrier permeability to macromolecules by optimized focused ultrasound combined with microbubblesEnhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound.Ultrasound-induced blood-brain barrier openingIn vivo transcranial cavitation threshold detection during ultrasound-induced blood-brain barrier opening in miceNoninvasive and targeted drug delivery to the brain using focused ultrasound.Microbubble-size dependence of focused ultrasound-induced blood-brain barrier opening in mice in vivo.Numerical study of a simple transcranial focused ultrasound system applied to blood-brain barrier opening.Multi-modality safety assessment of blood-brain barrier opening using focused ultrasound and definity microbubbles: a short-term study.Identifying the inertial cavitation threshold and skull effects in a vessel phantom using focused ultrasound and microbubbles.MRI-guided disruption of the blood-brain barrier using transcranial focused ultrasound in a rat modelCombining microbubbles and ultrasound for drug delivery to brain tumors: current progress and overview.Permeability dependence study of the focused ultrasound-induced blood-brain barrier opening at distinct pressures and microbubble diameters using DCE-MRIActivation of signaling pathways following localized delivery of systemically administered neurotrophic factors across the blood-brain barrier using focused ultrasound and microbubbles.A pilot study to assess markers of renal damage in the rodent kidney after exposure to 7 MHz ultrasound pulse sequences designed to cause microbubble translation and disruption.Dynamic study of blood-brain barrier closure after its disruption using ultrasound: a quantitative analysis.A quantitative pressure and microbubble-size dependence study of focused ultrasound-induced blood-brain barrier opening reversibility in vivo using MRI.Blood-brain barrier: real-time feedback-controlled focused ultrasound disruption by using an acoustic emissions-based controller.Optimization of the ultrasound-induced blood-brain barrier openingFocused-ultrasound disruption of the blood-brain barrier using closely-timed short pulses: influence of sonication parameters and injection rate.Noninvasive and localized blood-brain barrier disruption using focused ultrasound can be achieved at short pulse lengths and low pulse repetition frequenciesNoninvasive and localized neuronal delivery using short ultrasonic pulses and microbubbles.Targeted drug delivery across the blood-brain barrier using ultrasound technique.Influence of exposure time and pressure amplitude on blood-brain-barrier opening using transcranial ultrasound exposures.Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain.
P2860
Q26778701-765105D7-7070-4CAD-BC26-C71BA89EDB77Q27010023-7307952E-C5AF-47D9-AFD3-3E61BF475AD3Q27309999-50B6A1DE-B383-4A86-82CC-C9571A62F521Q28068242-61C3ED0D-8C59-4CBB-8DE6-15CD8759893FQ28253117-27800A9B-4F61-43E4-9756-1527EDD46197Q28539271-CE79005E-AF57-4EED-9AC1-632F68F8518CQ28539506-7ABB2EE5-3997-4B61-B37E-23787182C943Q30354561-DB18243C-18CC-4649-BD48-933007C1DBADQ30354625-2C3308FE-441E-4817-A7B2-00ACC3981110Q30362081-A113DAA1-DBBB-4A90-9361-2C5C71C87372Q30364611-D36EA1D9-CAC2-4FF1-98A1-889C9C0953CCQ30368351-4EDB690F-CBBD-4918-90BE-1F63CCA80A17Q30370894-ED5B9549-6552-4F49-A034-5925CCE7426DQ30407897-771E6609-457D-4B7E-8B88-E40357DE2EBCQ30411234-DC1C7726-35EA-452E-B939-32D5B7B3BF6DQ30424279-2B74E2A7-74DE-492B-9B0F-030DF965010DQ30430195-39761857-BDD8-4BD5-8D18-93AA5CB1366BQ30434707-EF245BB4-D167-40A0-8426-7C70140A0382Q30437732-1502B05A-385C-4DB9-B683-BCC16682C1C2Q30439400-9F59862B-3FB7-442D-A330-9AB4EDDBFD90Q30439968-CA81FA83-37B3-42CF-A550-2E1036803A2EQ30441135-03DF18A3-DAB2-43AA-9E9C-71BCDEF09041Q30441143-3F24F0D3-4B43-4503-88F6-367ABFCB7844Q30441159-B1FBB15E-28D5-4013-A984-68BE6AF9B3C8Q30441162-EB427BF3-B16A-4705-BFFF-B142454770BDQ30441775-E021C302-EA97-4308-B193-3EE6C96AE0ECQ30442623-63C72AA7-E210-48D5-BEA2-DA81ACBFF93CQ30443195-9E6DC6EC-B6F9-477F-AE4F-F5EFED87659AQ30443197-5260BFD8-48BF-4991-BE00-6813663D71CEQ30447313-C232A96E-D942-4A4A-982F-4814C7F72D53Q30448699-747D59D6-C5BF-4254-94BA-A2785AA19C5DQ30454507-8198B6E1-9125-4DE4-9327-03D68CF99494Q30455962-0C187B7F-44AE-40C5-AFFF-FFE130C1F4FEQ30458489-8D9963DF-AF7B-49F9-BB30-4458D946C182Q30469183-89A5A652-B1F2-4309-B0C1-20603F63CD94Q30470999-ACFC14A6-3961-43E3-A60F-AF7D5E41258AQ30473728-A773E9F8-B7B3-4E98-B201-4C0309C05B62Q30474781-2C1027E6-85FE-481C-8B30-03A1969C8F6FQ30475459-7A1550FC-B3F5-4918-9F0B-87EA12D7FE94Q30479578-2C293E26-654C-4F75-8C22-EF6554AE344E
P2860
Molecules of various pharmacologically-relevant sizes can cross the ultrasound-induced blood-brain barrier opening in vivo.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Molecules of various pharmacol ...... brain barrier opening in vivo.
@ast
Molecules of various pharmacol ...... brain barrier opening in vivo.
@en
type
label
Molecules of various pharmacol ...... brain barrier opening in vivo.
@ast
Molecules of various pharmacol ...... brain barrier opening in vivo.
@en
prefLabel
Molecules of various pharmacol ...... brain barrier opening in vivo.
@ast
Molecules of various pharmacol ...... brain barrier opening in vivo.
@en
P2093
P2860
P1476
Molecules of various pharmacol ...... brain barrier opening in vivo.
@en
P2093
Barclay Morrison
Shougang Wang
Yao-Sheng Tung
P2860
P356
10.1016/J.ULTRASMEDBIO.2009.08.006
P577
2010-01-01T00:00:00Z